Overall rank by patents
#31,943
of 49,997 tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Horizon Therapeutics Ireland DAC
USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Horizon ranks #31,943 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.
- #31,943
- of 49,997 US assignees by volume
- 27th percentile
- by Innovation Score (28.5/100)
- 21.6
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R31943 · Foreign Corporation #31,943 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 8 grants
- MID-PACK #31,943/49,997
- PHOTO-FINISH Honeybee Robotics
- CPC-NARROW A61P · 5 areas
- INNOV-THIN 28.5/100
- CLAIMS-DENSE 21.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Honeybee Robotics, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Innovation-score neighbourhood around Horizon
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Horizon Therapeutics… · this assignee 28
Horizon Therapeutics… · this assignee
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Horizon's Innovation Score is 28.5/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Where Horizon's grants concentrate
Horizon Therapeutics Ireland DAC is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Horizon sits between Honeybee Robotics, LLC and Huntar Company.
Who files at Horizon's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Honeybee Robotics
Honeybee Robotics, LLC
8 patents
- Hooker Furniture
Hooker Furniture Corporation
8 patents
- Hoowaki
Hoowaki, LLC
8 patents
- Horizon (Shanghai…
Horizon (Shanghai) Artificial Intelligence Technology Co., Ltd.
8 patents
- Hudson Institute…
Hudson Institute of Medical Research
8 patents
- Hughes Furniture…
Hughes Furniture Industries, Inc.
8 patents
- Human Biomolecula…
Human BioMolecular Research Institute
8 patents
- Huntar
Huntar Company
8 patents
- Horizon Therapeut… ◀
Horizon Therapeutics Ireland DAC
8 patents
What this shows Horizon holds 8 patents at rank #31,961, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Horizon
By rank, the assignees closest to #31,961 in granted patent volume.
- Honeybee Robotics, LLC #31,957 · 8 patents
- Hooker Furniture Corporation #31,958 · 8 patents
- Hoowaki, LLC #31,959 · 8 patents
- Horizon (Shanghai) Artificial Intelligence Technology Co., Ltd. #31,960 · 8 patents
- Hudson Institute of Medical Research #31,962 · 8 patents
- Hughes Furniture Industries, Inc. #31,963 · 8 patents
- Human BioMolecular Research Institute #31,964 · 8 patents
- Huntar Company #31,965 · 8 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Horizon's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Horizon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 27th percentile higher than 27% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 2 | 25.0% |
| 2025partial year | 6 | 75.0% |
Which technologies does Horizon Therapeutics Ireland DAC patent most?
Top 5 of 5 technology areas
What to do with this data
Horizon Therapeutics Ireland DAC's patent record in context - here's where to go next.
- Horizon Therapeutics Ireland DAC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #31,943 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Horizon Therapeutics Ireland DAC against Honeybee Robotics, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 28.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.